3rd Quarter - Report

INDEPENDENT PHARMACY COOPERATIVE for INDEPENDENT PHARMACY COOPERATIVE

Firm
Client
Income
—
Expenses
$40,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Pharmacy PHA

IPC supports Protecting Pharmacies in Medicaid Act (S.927). IPC supports PBM Reform Act of 2025 (HR 4317). IPC supports Patients Before Middlemen Act (S 882). IPC supports The Ensuring Community Access to Pharmacist Services Act of 2025 (ECAPS). CMS Implementation of drug provisions of the IRA 2022-including the drug negotiation provision with changes and prescription drug co-pay spread option. IPC supports the removal of the mandatory NADAC reporting requirement in the OBBB without an adequate and defined corresponding professional dispensing fee. IPC supports the Rural Health Transformation Program.

LobbyistCovered position, as disclosed
JOHN A. COVELLO —
MARK EUGENE KINNEY —

Contacted: Centers For Medicare and Medicaid Services (CMS); SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 4317 (119th), S. 927 (119th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.